Tokyo Tape
Sign in
← Qol Holdings

Quarterly report · Q1

3034.TEDINET S100ROAI
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥43.4bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥170.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥40.5bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥1.9bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥1.7bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥1.9bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥10.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.8bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥1.9bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥1.8bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥1.0bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.0bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥1.0bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥999m2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥104.0bnat 2023-06-30Cons.Assets
Total assets¥101.9bnat 2023-03-31Cons.Assets
Total assets¥98.1bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥54.7bnat 2023-06-30Cons.Liabilities
Total liabilities¥53.0bnat 2023-03-31Cons.Liabilities
Net assets / equity¥49.3bnat 2023-06-30Cons.Net assets
Net assets / equity¥48.9bnat 2023-03-31Cons.Net assets
Net assets / equity¥44.5bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥19.3bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥18.8bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥27.222023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥152.962022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥27.182022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio47.3%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio47.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio45.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥102m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥102m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥876m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2023-04-01 → 2023-06-30¥39.6bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2023-04-01 → 2023-06-30¥39.5bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥16m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2023-04-01 → 2023-06-30¥2.4bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue2023-04-01 → 2023-06-30¥3.9bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue external2023-04-01 → 2023-06-30¥3.9bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥86m
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentsegment profit2023-04-01 → 2023-06-30¥327m
—segment totalrevenue2023-04-01 → 2023-06-30¥43.5bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥43.4bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥102m
—segment totalsegment profit2023-04-01 → 2023-06-30¥2.7bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥77m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥77m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥830m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2022-04-01 → 2022-06-30¥37.2bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2022-04-01 → 2022-06-30¥37.2bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥17m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.1bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue2022-04-01 → 2022-06-30¥3.5bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue external2022-04-01 → 2022-06-30¥3.4bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥60m
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentsegment profit2022-04-01 → 2022-06-30¥349m
—segment totalrevenue2022-04-01 → 2022-06-30¥40.6bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥40.5bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥77m
—segment totalsegment profit2022-04-01 → 2022-06-30¥2.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 351
ItemContextValueUnit
Noncurrent assetsPrior1YearInstant57689000000JPY
Noncurrent assetsCurrentQuarterInstant57692000000JPY
Bond issuance cost daPrior1YearInstant1000000JPY
Bond issuance cost daCurrentQuarterInstant0JPY
Deferred assetsPrior1YearInstant1000000JPY
Deferred assetsCurrentQuarterInstant0JPY
AssetsPrior1YearInstant101905000000JPY
AssetsCurrentQuarterInstant104039000000JPY
Accounts payable tradePrior1YearInstant19958000000JPY
Accounts payable tradeCurrentQuarterInstant24498000000JPY
Current portion of bondsPrior1YearInstant608000000JPY
Current portion of bondsCurrentQuarterInstant398000000JPY
Current portion of long term loans payablePrior1YearInstant8104000000JPY
Current portion of long term loans payableCurrentQuarterInstant7390000000JPY
Income taxes payablePrior1YearInstant1976000000JPY
Income taxes payableCurrentQuarterInstant552000000JPY
Provision for bonusesPrior1YearInstant2310000000JPY
Provision for bonusesCurrentQuarterInstant1495000000JPY
Other clPrior1YearInstant3371000000JPY
Other clCurrentQuarterInstant5224000000JPY
Current liabilitiesPrior1YearInstant36330000000JPY
Current liabilitiesCurrentQuarterInstant39560000000JPY
Long term loans payablePrior1YearInstant14038000000JPY
Long term loans payableCurrentQuarterInstant12531000000JPY
Deferred tax liabilitiesPrior1YearInstant306000000JPY
Deferred tax liabilitiesCurrentQuarterInstant307000000JPY
Provision for directors retirement benefitsPrior1YearInstant34000000JPY
Provision for directors retirement benefitsCurrentQuarterInstant28000000JPY
Net defined benefit liabilityPrior1YearInstant829000000JPY
Net defined benefit liabilityCurrentQuarterInstant832000000JPY
Asset retirement obligations nclPrior1YearInstant1055000000JPY
Asset retirement obligations nclCurrentQuarterInstant1066000000JPY
Other nclPrior1YearInstant455000000JPY
Other nclCurrentQuarterInstant410000000JPY
Noncurrent liabilitiesPrior1YearInstant16719000000JPY
Noncurrent liabilitiesCurrentQuarterInstant15176000000JPY
LiabilitiesPrior1YearInstant53049000000JPY
LiabilitiesCurrentQuarterInstant54736000000JPY
Capital stockPrior1YearInstant5786000000JPY
Capital stockCurrentQuarterInstant5786000000JPY
Capital surplusPrior1YearInstant11276000000JPY
Capital surplusCurrentQuarterInstant11276000000JPY
Retained earningsPrior1YearInstant34355000000JPY
Retained earningsCurrentQuarterInstant34726000000JPY
Treasury stockPrior1YearInstant-2596000000JPY
Treasury stockCurrentQuarterInstant-2518000000JPY
Shareholders equityPrior1YearInstant48823000000JPY
Shareholders equityCurrentQuarterInstant49271000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant-14000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant-13000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass